GlycoMimetics Stock Price (NASDAQ:GLYC)

Add to My Stocks
$25.01 $0.34 (1.34%) GLYC stock closing price Feb 16, 2018 (Closing)
Prev Close* : $25.35
Market Cap:
$858.79M
Day Low: $24.59
52 Week Low: $3.82
Open: $25.3
Volume: -
Day High: $25.71
52 Week High: $26.05
Dividend:
0.00

Latest Stock Market News

Latest Articles

GlycoMimetics News - From Partners

GLYC Stockcharts

View GLYC PE ratio, PS ratio stocks charts and compare with peers.
GLYC Chart
Note: Compare GlycoMimetics stock price history with the index and industry peers.

GlycoMimetics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

GlycoMimetics Returns

ROE
(return on equity)
-49%

GlycoMimetics Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
-999.0000

GLYC Industry Peers

Company Price Change (%)
Flexion Therapeutics (FLXN)23.191.39 (5.66%)
Sucampo Pharma (SCMP)180 (0%)
Sangamo Therap (SGMO)23.30.3 (1.3%)
Bluebird Bio (BLUE)213.354.7 (2.25%)
Emisphere Tech (EMIS)0.340.01 (2.86%)
Alexion Pharma (ALXN)120.472.24 (1.83%)
Bristol-myers Squibb (BMY)68.960.02 (0.03%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)4.340.34 (8.5%)
ImmunoGen (IMGN)11.270.62 (5.82%)
ArQule (ARQL)1.720.09 (5.52%)
Nature's Sunshine Products (NATR)11.950.5 (4.37%)
Depomed (DEPO)7.440.28 (3.91%)
MediWound (MDWD)4.350.15 (3.57%)
Redhill Biopharma (RDHL)6.120.19 (3.2%)
Top gainers from Medical-Drugs industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Pacira Pharma (PCRX)30.155.95 (16.48%)
Flexion Therapeutics (FLXN)23.191.39 (5.66%)
Recro Pharma (REPH)8.30.4 (4.6%)
Arrowhead Pharma (ARWR)5.570.26 (4.46%)
Akebia Therapeutics (AKBA)14.140.64 (4.33%)
MOLECULAR TEMPL (MTEM)8.860.37 (4.01%)
Synergy Pharma (SGYP)2.030.08 (3.79%)
Top losers from Medical-Drugs industry
* As of Feb 17, 2018

GlycoMimetics Inc Stock News - Partner Headlines

GlycoMimetics Financial Statements

income statement20162015201420132012
Net Sales or Revenues-20.07M15.02M3.99M15.25M
Net Income-31.8M-12.76M-11.12M-10.6M3.65M
Total Operating Expense31.93M32.85M26.16M14.58M11.58M
View GlycoMimetics income statement
balance sheet20162015201420132012
Total Assets42.38M48.46M57.26M5.28M18.41M
Total Liabilities7.08M7.99M6.46M2.37M5.89M
Shareholders Equity35.3M40.47M50.8M2.9M12.52M
View GlycoMimetics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-1.07M2M5.04M-5.49M-14.64M
Net Cash from (used by) Operating Activities-29.73M-8.24M-4.28M-15.53M-10.47M
Increase (Decrease) in Prop Plant And Equipment-0.7M-0.26M-0.21M-0.08M-0.31M
View GlycoMimetics cash flow statement

GlycoMimetics Stock Message Board

GlycoMimetics stock lost 1.34%, and the last close price as of Feb 16, 2018 is $25.01 for GLYC stock. GlycoMimetics market capitalization is $858.79M and it represents the total market value of GLYC stock. GlycoMimetics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that GlycoMimetics is worth a lot, it will most likely be reflected in an inflated GlycoMimetics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in GlycoMimetics stock quote data shows the number of shares traded. For Ex: 469,970 GlycoMimetics shares were traded as of last trading day, as seen from GlycoMimetics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. GlycoMimetics does not pay dividends. To check the historical stock price movement, all time high, and all time low of GLYC, view GlycoMimetics stock price history.